- Home
- KRRO vs SOPH Comparison
KRRO vs SOPH Comparison
Compare KRRO & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- SOPH
- Stock Information
- Founded
- KRRO 2014
- SOPH 2011
- Country
- KRRO United States
- SOPH Switzerland
- Employees
- KRRO N/A
- SOPH 423
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KRRO Health Care
- SOPH Health Care
- Exchange
- KRRO Nasdaq
- SOPH Nasdaq
- Market Cap
- KRRO 209.6M
- SOPH 193.8M
- IPO Year
- KRRO 2019
- SOPH 2021
- Fundamental
- Price
- KRRO $11.42
- SOPH $3.00
- Analyst Decision
- KRRO Strong Buy
- SOPH Strong Buy
- Analyst Count
- KRRO 7
- SOPH 2
- Target Price
- KRRO $85.67
- SOPH $6.50
- AVG Volume (30 Days)
- KRRO 89.6K
- SOPH 24.1K
- Earning Date
- KRRO 05-07-2025
- SOPH 05-06-2025
- Dividend Yield
- KRRO N/A
- SOPH N/A
- EPS Growth
- KRRO N/A
- SOPH N/A
- EPS
- KRRO N/A
- SOPH N/A
- Revenue
- KRRO $4,821,000.00
- SOPH $67,173,000.00
- Revenue This Year
- KRRO $20.96
- SOPH $15.88
- Revenue Next Year
- KRRO N/A
- SOPH $24.07
- P/E Ratio
- KRRO N/A
- SOPH N/A
- Revenue Growth
- KRRO N/A
- SOPH 4.66
- 52 Week Low
- KRRO $11.00
- SOPH $2.58
- 52 Week High
- KRRO $98.00
- SOPH $5.63
- Technical
- Relative Strength Index (RSI)
- KRRO 34.02
- SOPH 51.16
- Support Level
- KRRO $14.54
- SOPH $2.82
- Resistance Level
- KRRO $16.68
- SOPH $3.10
- Average True Range (ATR)
- KRRO 1.49
- SOPH 0.19
- MACD
- KRRO -0.33
- SOPH -0.00
- Stochastic Oscillator
- KRRO 6.24
- SOPH 42.22
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.